- Jul 2018
-
europepmc.org europepmc.org
-
On 2015 Nov 29, Mauro De Rosa commented:
Replacing branded medicines with generic ones
In most countries, regulatory agencies have the responsibility of indicating the situations in which branded medicines can be substituted by equivalent ones (i.e. generics). In Italy, these regulatory recommendations have been issued by our national medicine agency (AIFA) by indicating the exceptions, i.e. those cases where a branded medicine cannot be replaced by the equivalent counterpart. A total of six such cases have been identified in Italy, which included the following agents: levetiracetam and topiramate (1), levotyroxine (2), cyclosporine (3), metformine + glibenclamide (4), tacrolimus (5).
References
AIFA website - Specialità medicinali contenenti Levetiracetam e Topiramato (17/09/2012), http://www.agenziafarmaco.gov.it/it/content/specialità-medicinali-contenenti-levetiracetam-e-topiramato-17092012); accessed 3.9.2015
AIFA website - http://www.agenziafarmaco.gov.it/it/content/precisazione-aifa-sulla-prescrizione-base-di-levotiroxina-15122014 accessed 30.10.2015
AIFA website - http://www.agenziafarmaco.gov.it/it/content/precisazioni-aifa-su-specialità-medicinali-contenenti-ciclosporina-15042015 Precisazioni AIFA del 15 aprile 2015 su specialità medicinali contenenti ciclosporina accessed 3.9.2015
AIFA website http://www.agenziafarmaco.gov.it/it/content/liste-di-trasparenza-metformina-e-glibenclamide-500-mg-5-mg accessed 3.9.2015
AIFA website http://www.agenziafarmaco.gov.it/it/content/precisazioni-aifa-su-specialità-medicinali-contenenti-tacrolimus accessed 3.9.2015
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
europepmc.org europepmc.org
-
On 2015 Nov 29, Mauro De Rosa commented:
Replacing branded medicines with generic ones
In most countries, regulatory agencies have the responsibility of indicating the situations in which branded medicines can be substituted by equivalent ones (i.e. generics). In Italy, these regulatory recommendations have been issued by our national medicine agency (AIFA) by indicating the exceptions, i.e. those cases where a branded medicine cannot be replaced by the equivalent counterpart. A total of six such cases have been identified in Italy, which included the following agents: levetiracetam and topiramate (1), levotyroxine (2), cyclosporine (3), metformine + glibenclamide (4), tacrolimus (5).
References
AIFA website - Specialità medicinali contenenti Levetiracetam e Topiramato (17/09/2012), http://www.agenziafarmaco.gov.it/it/content/specialità-medicinali-contenenti-levetiracetam-e-topiramato-17092012); accessed 3.9.2015
AIFA website - http://www.agenziafarmaco.gov.it/it/content/precisazione-aifa-sulla-prescrizione-base-di-levotiroxina-15122014 accessed 30.10.2015
AIFA website - http://www.agenziafarmaco.gov.it/it/content/precisazioni-aifa-su-specialità-medicinali-contenenti-ciclosporina-15042015 Precisazioni AIFA del 15 aprile 2015 su specialità medicinali contenenti ciclosporina accessed 3.9.2015
AIFA website http://www.agenziafarmaco.gov.it/it/content/liste-di-trasparenza-metformina-e-glibenclamide-500-mg-5-mg accessed 3.9.2015
AIFA website http://www.agenziafarmaco.gov.it/it/content/precisazioni-aifa-su-specialità-medicinali-contenenti-tacrolimus accessed 3.9.2015
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-